Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Global Crop Innovations Pty Ltd. currently manages 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This action is assigned to 1 distinct examiner and is situated within 1 distinct art unit. This concentration indicates that the company's current active prosecution is focused on a specific matter, requiring a targeted strategy to address the requirements of the assigned examiner and art unit.
The busiest examiner for this portfolio is MCWILLIAMS, KELSEY LYNN, who is responsible for 1 pending office action. Because this individual is the only examiner currently handling an active case for the company, their perspective and examination style will be the primary factor in the immediate progress of the portfolio. Practitioners should review the past decisions of the named examiner to prepare a response to the outstanding matter.
The presence of 1 pending office action and 1 distinct art unit means that the administrative requirements for this portfolio relate to these specific points of contact. The absence of other pending matters means that the company's current advancement in its technology field depends on the outcome of this prosecution. Practitioners should focus on building an argument to navigate the case under the assigned official.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MCWILLIAMS, KELSEY LYNN | 1 | 89.2% | +5.8% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18320433 | BLUE ALEURONE AND OTHER SEGREGATION SYSTEMS | MCWILLIAMS, KELSEY LYNN | — |
| Art Unit | Apps |
|---|---|
| 1663 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18320433 | BLUE ALEURONE AND OTHER SEGREGATION SYSTEMS | MCWILLIAMS, KELSEY LYNN | 1663 | §112DP | Non-Final OA | — | Pending | May 19, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialGlobal Crop Innovations Pty Ltd. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Kelsey Lynn Mcwilliams has the most, with 1 of Global Crop Innovations Pty Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
